Kasturba Medical College, Manipal, India (A.K.).
Division of Cardiology, Duke Clinical Research Institute, Duke University School of Medicine, Durham, NC (M.F., R.J.M.).
Circ Heart Fail. 2021 Dec;14(12):e008403. doi: 10.1161/CIRCHEARTFAILURE.121.008403. Epub 2021 Oct 27.
Bedside evaluation of congestion is a mainstay of heart failure (HF) management. Whether detected physical examination signs have changed over time as obesity prevalence has increased in HF populations, or if the associated prognosis differs for HF with reduced or preserved ejection fraction (HFrEF or HFpEF) is uncertain.
From 2005 to 2014, the ARIC study (Atherosclerosis Risk in Communities) conducted adjudicated hospital surveillance of acute decompensated HF. We analyzed trends in physical examination findings, imaging signs, and symptoms related to congestion, both over time and by obesity class, and associated 28-day mortality risks.
Of 24 937 weighted hospitalizations for acute decompensated HF (mean age 75 years, 53% women, 32% Black), 47% had HFpEF. The prevalence of obesity increased from 2005 to 2014 for both HF types. With increasing obesity category, detected edema increased, while jugular venous distension decreased, and rales remained stable. Detected edema also increased over time, for both HF types. Associations between 28-day mortality and individual signs and symptoms of congestion were similar for HFpEF and HFrEF; however, the adjusted mortality risk with all 3 (edema, rales, and jugular venous distension) versus <3 physical examination findings was higher for patients with HFpEF (odds ratio, 2.41 [95% CI, 1.53-3.79]) than HFrEF (odds ratio, 1.30 [95% CI, 0.87-1.93]); for interaction by HF type =0.02.
In patients hospitalized with acute decompensated HF, detected physical examination findings differ both temporally and by obesity. Combined findings from the physical examination are more prognostic of 28-day mortality for patients with HFpEF than HFrEF.
床边评估充血是心力衰竭(HF)管理的主要方法。随着肥胖症在 HF 人群中的发病率增加,体检时发现的体征是否随时间发生了变化,或者对于射血分数降低或保留的 HF(HFrEF 或 HFpEF),相关预后是否不同,目前尚不确定。
2005 年至 2014 年,ARIC 研究(社区动脉粥样硬化风险研究)对急性失代偿性 HF 进行了有裁决的医院监测。我们分析了随着时间的推移和肥胖程度,与充血相关的体检发现、影像学征象和症状的趋势,以及与 28 天死亡率相关的风险。
在 24937 例加权急性失代偿性 HF 住院患者中(平均年龄 75 岁,53%为女性,32%为黑人),47%为 HFpEF。两种 HF 类型的肥胖患病率均从 2005 年至 2014 年增加。随着肥胖程度的增加,检出的水肿增加,而颈静脉扩张减少,啰音保持稳定。两种 HF 类型的水肿也随时间增加。HFpEF 和 HFrEF 患者的充血的单个体征和症状与 28 天死亡率之间的关联相似;然而,与<3 项体检发现相比,所有 3 项(水肿、啰音和颈静脉扩张)与 HFpEF(比值比,2.41 [95%CI,1.53-3.79])患者的调整死亡率风险高于 HFrEF(比值比,1.30 [95%CI,0.87-1.93]);HF 类型的交互作用 P 值=0.02。
在因急性失代偿性 HF 住院的患者中,体检时发现的体征既随时间变化,也因肥胖程度而异。与 HFrEF 相比,HFpEF 患者的体检综合发现对 28 天死亡率的预测性更强。